Dr. Lockwood Audio Issue: February 2012


Dr. Lockwood Audio Issue: February 2012

It's almost time for your next issue of Contemporary OB/GYN.

Editor-in-Chief Dr. Charles J. Lockwood gives you a preview of the upcoming issue: features and practice pearls from ob/gyn key opinion leaders, news and analysis, Legally Speaking, and more.

Moderator: We're here with Editor in Chief Dr. Charles J. Lockwood, Dean of the College of Medicine and Vice President for Health Sciences at The Ohio State University.

Dr. Lockwood, what can you tell us about the upcoming issue of Contemporary OB/GYN?

Dr. Lockwood: The February issue of Contemporary OB/GYN is packed, from cover to cover, with information you can use in day-to-day practice. Here are highlights of our must-read articles and departments:

Examining the Evidence on Vitamin D, Calcium and Risk of CVD
The role vitamin D and calcium play in preventing CVD is a subject of intense interest and debate. In this month’s cover story, epidemiologist JoAnn E. Manson and her colleagues from the HSPH examine evidence from observational and RCTs. With more and more adults taking vitamin D and calcium supplements, it’s clear that far more data are needed to elucidate the potential risk and benefits of these micronutrients to cardiovascular health.

Should You Use Hypoglycemic Agents to Manage Gestational Diabetes?
As many as 10% of pregnancies in the United States are complicated by GDM and are at increased risk for macrosomia, shoulder dystocia, and neonatal hyperglycemia. When euglycemia can’t be achieved with diet and exercise, the gold standard for GDM is insulin. But should you prescribe oral hypoglycemic agents? Dr. Lisa Moore of the University of New Mexico answers that question in a review that assesses the safety, efficacy, and economic impact of glyburide and metformin.

What You Need to Know Before Prescribing the Latest OCs
OCs remain the most popular method of reversible birth control in the United States, and more than 50 years after the introduction of “the pill,” pharmaceutical companies continue to develop new formulations. Many gynecologists are hesitant to prescribe newer pills out of concern about efficacy and safety. In this review, Jeffrey Jensen of the Oregon Health and Science University looks at data on new estrogens and progestins employed in novel dosing regimens and gives you the information you need to make well-reasoned prescribing decisions.

Moderator: For nearly half a century, busy practitioners have trusted Contemporary OB/GYN to translate the latest research into outstanding patient care. We're dedicated to providing you with evidence-based information on scientific advances in a clinically useful format.

Related Videos
Shocking maternal health findings from 2023 March of Dimes report card | Image Credit: marchofdimes.org
The importance of maternal vaccination | Image Credit: nfid.org.
Expert on OAB
Expert on OAB
How to address sexual dysfunction during menopause | Image Credit: health.usnews.com
Hot flashes poorly impact sleep quality | Image Credit: intimmedicine.com
Experts on OAB
Expert on OAB
Expert on OAB
Related Content
© 2023 MJH Life Sciences

All rights reserved.